Pediatric Neurology

Latest News

Early Escalation to Highly Effective Drugs May Reduce Cognitive Impairment in Pediatric Multiple Sclerosis

Early initiation of highly effective escalation therapies in pediatric patients with MS is associated with reduced cognitive impairment and may prevent cognitive decline.

Advanced MRI Highlights Long-Term Effect of Concussion in Athletes

Multimodal MRI in concussed athletes highlights persistent effects on CBF and mean diffusivity 1 year after medical clearance to return to play.

Majority of Cases of Childhood Encephalitis Caused by Viral Infections

Causes of childhood encephalitis are predominated by epidemic viral infections and frequently include vaccine-preventable diseases.

Fast MRI Appropriate for Evaluation of Children With Traumatic Brain Injury

Fast MRI is a reasonable alternative to CT for evaluation of children with traumatic brain injury.

Management of Pediatric Migraine: Headache vs Non-Headache Specialists

Headache specialist was more likely to use triptans, while non-headache specialists and the headache specialist started prophylaxis at similar rates in eligible participants.

Effect of Fluoxetine on Repetitive Behaviors in Children With Autism Unclear

Treatment with fluoxetine appears to result in significantly lower scores for obsessive compulsive behaviors at 16 weeks among children and adolescents with ASD, but interpretation of the data is limited.

Safety of Endovascular Thrombectomy in Children With Ischemic Stroke Comparable to That in Adults

Mechanical thrombectomy is safe in childhood stroke and was found to have a similar safety profile to that reported in adult trials.

Prenatal Exposure to Endocrine-Disrupting Chemicals Linked to Lower Childhood IQ

Exposure to endocrine-disrupting chemicals in the first trimester of pregnancy may affect intellectual functioning in childhood.

Interventions Aimed at Combating Stunted Growth During Childhood May Not Extend to Neurobehavioral Development

Interventions that target linear growth in childhood such as those aimed at combating malnutrition may not provide concurrent benefits in neurodevelopment.

OnabotulinumtoxinA Approved for Pediatric Lower Limb Spasticity

The FDA has approved Botox for the treatment of lower limb spasticity in pediatric patients 2 to 17 years of age, excluding spasticity caused by cerebral palsy. The treatment was already approved for pediatric upper limb spasticity earlier this year.